Illumina

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Illumina, Inc. (ILMN)

Retrieved on: 
Tuesday, November 14, 2023
Acquisition, GRAIL, SAN, LLP, Complaint, Illumina, Inc., European, Person, ILMN, News, Cryptocurrency, Reuters, Illumina, Inc.

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (NASDAQ: ILMN) securities between May 1, 2023 and October 16, 2023.

Key Points: 
  • SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (NASDAQ: ILMN) securities between May 1, 2023 and October 16, 2023.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • After GRAIL raised $1.9 billion through venture capital and strategic partners, Illumina announced plans to reacquire GRAIL in September 2020.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Illumina, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

Class Action Lawsuit Filed Against Illumina, Inc. (ILMN) on Behalf of Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Retrieved on: 
Tuesday, November 14, 2023
ISS, Icahn, Fraud, Loss, GRAIL, Czarnik v. Illumina Inc., Illumina

ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN).

Key Points: 
  • ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN).
  • at [email protected] , by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/illumina/ to learn more.
  • Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation.
  • Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses

Retrieved on: 
Friday, November 10, 2023
Defendant, Acquisition, Behavior, GRAIL, Remuneration, Reuters, Illumina, Inc., Icahn, Court, Financial services, Illumina

Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .

Key Points: 
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • Following this announcement, Illumina's share price dropped by $4.64, or 2.5%, ending at $180.48 on August 11, 2023.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools

Retrieved on: 
Tuesday, December 12, 2023
Professional Services, Finance, Disclosure, Indian psychology, WGS, NYSE, Viking Global Investors, Shareholder, Acquisition, Thermo Fisher Scientific, Security (finance), Therapy, PIPE, Combination, Proteomics, CFO, Investment, Depression, GREEN, Standard, Serum, Illumina, Inc., TMO, Weather, Special, Partnership, Mergers and acquisitions, Growth, Puerto Madryn, Environment, Holding company, Fine chemical, Cryptocurrency, Retail, Bank, Plasma, Series, SomaLogic, Illumina

Additionally, Madryn announced it has filed a preliminary proxy statement with the Securities and Exchange Commission (“SEC”) in order to solicit proxies in opposition to the Merger.

Key Points: 
  • Additionally, Madryn announced it has filed a preliminary proxy statement with the Securities and Exchange Commission (“SEC”) in order to solicit proxies in opposition to the Merger.
  • That is why we intend to vote AGAINST the Merger at the upcoming Special Meeting on January 4, 2024.
  • Additionally, we have taken steps to soon be in a position to actively solicit your votes AGAINST the Merger.
  • In the meantime, we urge you to reach out to SomaLogic to express your views on the Merger.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Illumina, Inc. (ILMN) Investors and Encourages Investors to Contact the Firm Before January 9, 2024

Retrieved on: 
Friday, December 1, 2023
Class Action Lawsuit, Professional Services, Legal, GRAIL, Acquisition, LLP, Complaint, Illumina, Inc., Icahn, District court, Court, News, Tobacco, Reuters, Illumina

Investors have until January 9, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 9, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
  • Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com .

ILMN Shareholders Upcoming Deadline: Bronstein, Gewirtz & Grossman LLC Reminds Investors of The Illumina, Inc. to Contact the Firm

Retrieved on: 
Thursday, November 30, 2023
Class Action Lawsuit, Professional Services, Legal, Defendant, Icahn, GRAIL, Czarnik v. Illumina Inc., Court, Complaint, Person, Insurance, Illumina

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN) and certain of its officers.

Key Points: 
  • Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN) and certain of its officers.
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ilmn .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Retrieved on: 
Wednesday, November 29, 2023
Other Health, Research, General Health, Oncology, Technology, Genetics, Science, Cardiology, Neurology, Other Technology, Other Science, Health, Pacific Biosciences, Molecular biology, Genomics, Multimedia, Doctor of Philosophy, Marketing, University, Cancer, Growth, CCO, Single-cell analysis, Management, Illumina

BioSkryb Genomics , a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram Laxman, Ph.D., as Chief Commercial Officer.

Key Points: 
  • BioSkryb Genomics , a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram Laxman, Ph.D., as Chief Commercial Officer.
  • Dr. Laxman will lead sales and support, commercial strategy and operations, and marketing as BioSkryb continues to scale its global presence.
  • View the full release here: https://www.businesswire.com/news/home/20231129687097/en/
    BioSkryb has appointed Ram Laxman, Ph.D., as Chief Commercial Officer.
  • (Photo: Business Wire)
    Dr. Laxman joins BioSkryb from 10x Genomics, where he served as the President and General Manager, APAC.

ILMN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Illumina, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Tuesday, November 28, 2023
Class Action Lawsuit, Professional Services, Legal, Defendant, Icahn, GRAIL, Czarnik v. Illumina Inc., Court, Complaint, Person, Insurance, Illumina

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN) and certain of its officers.

Key Points: 
  • Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN) and certain of its officers.
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ilmn .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

ILMN Stock News: Shareholders with Significant Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against Illumina, Inc.

Retrieved on: 
Monday, November 20, 2023
Class Action Lawsuit, Professional Services, Legal, Acquisition, GRAIL, LLP, Complaint, Illumina, Inc., European, Person, ILMN, News, Cryptocurrency, Reuters, Illumina, Inc.

For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

Key Points: 
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • After several capital financing rounds, Illumina spun off GRAIL in February 2017 and retained a stake of approximately 20%.
  • After GRAIL raised $1.9 billion through venture capital and strategic partners, Illumina announced plans to reacquire GRAIL in September 2020.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Illumina, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

ILMN Investor Announcement: Kessler Topaz Meltzer & Check, LLP Announces January 9, 2024 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Illumina, Inc. (ILMN)

Retrieved on: 
Friday, November 17, 2023
Class Action Lawsuit, Professional Services, Legal, COPY, Acquisition, GRAIL, Reuters, LLP, Complaint, Insurance, Icahn, District court, Lead, Court, Letter, News, Illumina

Kessler Topaz Meltzer & Check, LLP encourages Illumina investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Illumina investors who have suffered significant losses to contact the firm directly to acquire more information.
  • A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.